DERMATOLOGICALS IN COLOMBIA

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Growth Driven by Antifungals

Mixed Performances for Other Dermatologicals

Competitive Landscape

Dermatologicals Led by Foreign Companies

Mixed Performance for Sanofi-aventis Pharma

Private Label Remains Underdeveloped

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018

Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Executive Summary

Consumer Health Records Growth in 2018 As Economy Begins Recovery

Main Switches Present in Digestive Remedies and Cough, Cold and Allergy Remedies

Foreign Companies Lead Most Consumer Health Categories

Chemists/pharmacies Continues To Be Leading Distribution Channel

Increasing Awareness of Self-care and Ageing Population To Boost Future Sales

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches From Prescription to OTC

Summary 2 OTC: Switches From OTC to Prescription

Sources

Summary 3 Research Sources

Dermatologicals has traditionally been surrounded by social stigmas, especially around vaginal and topical antifungals. However, in 2018, this stigma continued to be less relevant, along with increasing confidence in these products to address minor ailments, which led to increasing sales in 2018. Antifungals held the largest value share within dermatologicals (combining topical and vaginal).

Euromonitor International's Dermatologicals in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.